|
1
|
Yu Y, Guan H, Xing LG and Xiang YB: Role
of gross tumor volume in the prognosis of non-small cell lung
cancer treated with 3D conformal radiotherapy: a meta-analysis.
Clin Ther. 37:2256–2266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Daga A, Ansari A, Patel S, Mirza S, Rawal
R and Umrania V: Current drugs and drug targets in non-small cell
lung cancer: limitations and opportunities. Asian Pac J Cancer
Prev. 16:4147–4156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmitt AM and Chang HY: Long non-coding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang Y, He R, An J, Deng P, Huang L and
Yang W: lncRNA XIST interacts with miR-140 to modulate lung cancer
growth by targeting iASPP. Oncol Rep. 38:941–948. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zhu H, Yin L, Wang T, Wu J, Xu J,
Tao H, Liu J and He X: lncRNA-PVT1 facilitates invasion through
upregulation of MMP9 in nonsmall cell lung cancer cell. DNA Cell
Biol. 36:787–793. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castellano JJ, Navarro A, Viñolas N,
Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D,
Molins L, et al: LincRNA-p21 impacts prognosis in resected
non-small cell lung cancer patients through angiogenesis
regulation. J Thorac Oncol. 11:2173–2182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo X and Hua Y: CCAT1: an oncogenic long
non-coding RNA in human cancers. J Cancer Res Clin Oncol.
143:555–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao J and Cheng L: Long non-coding RNA
CCAT1/miR-148a axis promotes osteosarcoma proliferation and
migration through regulating PIK3IP1. Acta Biochim Biophys Sin.
49:503–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen S, Ma P, Li B, Zhu D, Chen X, Xiang
Y, Wang T, Ren X, Liu C and Jin X: LncRNA CCAT1 inhibits cell
apoptosis of renal cell carcinoma through up-regulation of Livin
protein. Mol Cell Biochem. May 3–2017.(Epub ahead of print). doi:
10.1007/s11010-017-3043-8. View Article : Google Scholar
|
|
10
|
Arunkumar G, Murugan AK, Prasanna
Srinivasa Rao H, Subbiah S, Rajaraman R and Munirajan AK: Long
non-coding RNA CCAT1 is overexpressed in oral squamous cell
carcinomas and predicts poor prognosis. Biomed Rep. 6:455–462.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Miao R, Liu S, Wan Y, Zhang S, Deng
Y, Bi J, Qu K, Zhang J and Liu C: Down-regulation of miR-146b-5p by
long non-coding RNA MALAT1 in hepatocellular carcinoma promotes
cancer growth and metastasis. Oncotarget. 8:28683–28695.
2017.PubMed/NCBI
|
|
13
|
Sanchez-Palencia A, Gomez-Morales M,
Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R and Fárez-Vidal ME:
Gene expression profiling reveals novel biomarkers in nonsmall cell
lung cancer. Int J Cancer. 129:355–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng J, Sun Y, Zhang EB, Lu XY, Jin SD and
Guo RH: A novel long non-coding RNA IRAIN regulates cell
proliferation in non small cell lung cancer. Int J Clin Exp Pathol.
8:12268–12275. 2015.PubMed/NCBI
|
|
15
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q, et al: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su L, Han D, Wu J and Huo X: Skp2
regulates non-small cell lung cancer cell growth by Meg3 and
miR-3163. Tumour Biol. 37:3925–3931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH, et al: Long non-coding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang XF, Liu T, Li Y and Li S:
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of
poor prognosis in patients with breast cancer. Int J Clin Exp
Pathol. 8:9440–9445. 2015.PubMed/NCBI
|
|
20
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long non-coding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu SP, Yang JX, Cao DY and Shen K:
Identification of differentially expressed long non-coding RNAs in
human ovarian cancer cells with different metastatic potentials.
Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI
|
|
22
|
Bischof O and Martínez-Zamudio RI:
MicroRNAs and lncRNAs in senescence: A re-view. IUBMB Life.
67:255–267. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng L, Yang SB, Xu FF and Zhang JH: Long
non-coding RNA CCAT1 promotes hepatocellular carcinoma progression
by functioning as let-7 sponge. J Exp Clin Cancer Res. 34:182015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang ZH, Guo XQ, Zhang QS, Zhang JL, Duan
YL, Li GF and Zheng DL: Long non-coding RNA CCAT1 promotes glioma
cell proliferation via inhibiting microRNA-410. Biochem Biophys Res
Commun. 480:715–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Zhang W and Hao S: LncRNA CCAT1
modulates the sensitivity of paclitaxel in nasopharynx cancers
cells via miR-181a/CPEB2 axis. Cell Cycle. 16:795–801. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao L, Bombard J, Cintron K, Sheedy J,
Weetall ML and Davis TW: BMI1 as a novel target for drug discovery
in cancer. J Cell Biochem. 112:2729–2741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiong D, Ye Y, Fu Y, Wang J, Kuang B, Wang
H, Wang X, Zu L, Xiao G, Hao M, et al: Bmi-1 expression modulates
non-small cell lung cancer progression. Cancer Biol Ther.
16:756–763. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Tian T, Sun W, Liu C and Fang X:
Bmi-1 overexpression as an efficient prognostic marker in patients
with nonsmall cell lung cancer. Medicine. 96:e73462017. View Article : Google Scholar : PubMed/NCBI
|
